Moderna announced Tuesday it is filing for full U.S. Food and Drug Administration (FDA) approval of its COVID-19 vaccine.
Right now, the vaccine is only authorized for emergency use.
Full approval would allow Moderna to market the vaccine directly. Approval could also help curb vaccine hesitancy.
Moderna said it will submit data to the FDA on a rolling basis over the coming weeks. The FDA will tell Moderna when their data has been accepted for review.
Pfizer sought full approval for its vaccine last month.